The total or near total disappearance of the tumor in the resected specimen after neoadjuvant chemotherapy indicates the achievement of a pathological complete response (pCR), which is considered a powerful predictor of survival and good prognosis, especially in more aggressive subtypes like triple-negative or Her-2-positive breast cancers [7]. The gene discussed is ERBB2; the disease is neoplasm.